 interviewed Ronald T. Piervincenzi, CEO of US Pharmacopeia (USP), on a recent USP survey that showed 9 out of 10 physicians feel their trust in the ability of the US supply chain to deliver safe, quality medicines has eroded.

During the interview, Piervincenzi addressed how drug shortages are related to medicine quality issues and why medicine quality may have been impacted during the COVID-19 pandemic.

News

503B Compounding Pharmacy

® 503B Compounding Pharmacy Resource Center is a comprehensive resource for clinical news and expert insights on issues related to compounding pharmacies and drug safety.

Coronavirus

® Coronavirus Disease Resource Center is a comprehensive resource for clinical news and expert insights on COVID-19, an infectious disease caused by the SARS-CoV-2 virus, including vaccine information and treatments for the disease.

Hospital

® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.

Retail

® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how drug shortages are related to medicine quality issues.

USP CEO: Why Medicine Quality May Have Been Impacted During the Pandemic